Polyunsaturated fatty acids and fatty acid-derived lipid mediators: Recent advances in the understanding of their biosynthesis, structures, and functions

SC Dyall, L Balas, NG Bazan, JT Brenna… - Progress in lipid …, 2022 - Elsevier
Polyunsaturated fatty acids (PUFAs) are structural components of membrane phospholipids,
and influence cellular function via effects on membrane properties, and also by acting as a …

Formation, signaling and occurrence of specialized pro-resolving lipid mediators—what is the evidence so far?

NH Schebb, H Kühn, AS Kahnt, KM Rund… - Frontiers in …, 2022 - frontiersin.org
Formation of specialized pro-resolving lipid mediators (SPMs) such as lipoxins or resolvins
usually involves arachidonic acid 5-lipoxygenase (5-LO, ALOX5) and different types of …

Resolution pharmacology: focus on pro-resolving annexin A1 and lipid mediators for therapeutic innovation in inflammation

M Perretti, J Dalli - Annual Review of Pharmacology and …, 2023 - annualreviews.org
Chronic diseases that affect our society are made more complex by comorbidities and are
poorly managed by the current pharmacology. While all present inflammatory …

Resolvin T-series reduce neutrophil extracellular traps

N Chiang, M Sakuma, AR Rodriguez… - Blood, The Journal …, 2022 - ashpublications.org
The newly identified 13-series (T-series) resolvins (RvTs) regulate phagocyte functions and
accelerate resolution of infectious inflammation. Because severe acute respiratory syndrome …

SARS-CoV-2 infection and lung regeneration

F Zhao, Q Ma, Q Yue, H Chen - Clinical Microbiology Reviews, 2022 - Am Soc Microbiol
The lung is the primary site of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2)-induced immunopathology whereby the virus enters the host cells by binding to …

E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing …

CN Serhan, S Libreros, R Nshimiyimana - Seminars in immunology, 2022 - Elsevier
The COVID-19 pandemic has raised international awareness of the importance of rigorous
scientific evidence and the havoc caused by uncontrolled excessive inflammation. Here we …

Pulmonary delivery of specialized pro-resolving mediators-based nanotherapeutics attenuates pulmonary fibrosis in preclinical animal models

J Li, Y Xiao, Y Zhang, S Li, M Zhao, T Xia, H Meng - ACS nano, 2023 - ACS Publications
Pulmonary fibrosis (PF) is a chronic lung disease characterized by excess extracellular
matrix deposition and prolonged inflammation that fails to resolve and is druggable. Using …

Pneumonia-induced inflammation, resolution and cardiovascular disease: causes, consequences and clinical opportunities

C Stotts, VF Corrales-Medina, KJ Rayner - Circulation research, 2023 - Am Heart Assoc
Pneumonia is inflammation in the lungs, which is usually caused by an infection. The
symptoms of pneumonia can vary from mild to life-threatening, where severe illness is often …

Glucocorticoids regulate lipid mediator networks by reciprocal modulation of 15-lipoxygenase isoforms affecting inflammation resolution

Z Rao, E Brunner, B Giszas… - Proceedings of the …, 2023 - National Acad Sciences
Glucocorticoids (GC) are potent anti-inflammatory agents, broadly used to treat acute and
chronic inflammatory diseases, eg, critically ill COVID-19 patients or patients with chronic …

Dysregulated plasma lipid mediator profiles in critically ill COVID-19 patients

F Palmas, J Clarke, RA Colas, EA Gomez, A Keogh… - PloS one, 2021 - journals.plos.org
Coronavirus disease (COVID)-19, as a result of Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) infection, has been the direct cause of over 2.2 million deaths …